A weekly HIV drug could offer more options for patients

Embargoed until: Publicly released: 2026-07-30 04:35

International

HIV-1 Virus Particles Transmission electron micrograph of HIV-1 virus particles (colorized red) replicating from an HIV-infected H9 T-cell (blue). Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Photo by National Institute of Allergy and Infectious Diseases on Unsplash

A weekly HIV drug could help patients stick to their treatment regimen, according to international researchers. The team ran a randomised controlled trial with 607 HIV patients across 12 countries, and the once-weekly oral drug was not found to be worse than the once-daily tablet at maintaining suppression of the HIV viral load. The team says the new drug could offer more options for people with HIV, particularly as daily medications sometimes can be easier to forget.

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Queen Mary University of London, UK

Funder: No funding information provided.

Media Contact/s

Contact details are only visible to registered journalists.